The sensitivity of gastric cancer to trastuzumab is regulated by the miR-223/FBXW7 pathway (Q38962587)

8 September 2017

The sensitivity of gastric cancer to trastuzumab is regulated by the miR-223/FBXW7 pathway (English)

1 reference

8 September 2017

1 reference

Kojiro Eto

1

1 reference

8 September 2017

Masaaki Iwatsuki

2

1 reference

8 September 2017

Masayuki Watanabe

3

1 reference

8 September 2017

Takatsugu Ishimoto

4

1 reference

8 September 2017

Satoshi Ida

5

1 reference

8 September 2017

Yu Imamura

6

1 reference

8 September 2017

Shiro Iwagami

7

1 reference

8 September 2017

Yoshifumi Baba

8

1 reference

8 September 2017

Yasuo Sakamoto

9

1 reference

8 September 2017

Yuji Miyamoto

10

1 reference

8 September 2017

Naoya Yoshida

11

1 reference

8 September 2017

Hideo Baba

12

1 reference

8 September 2017

language of work or name

English

0 references

publication date

11 September 2014

1 reference

International Journal of Cancer

8 September 2017

9

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

8 September 2017

136

1 reference

8 September 2017

7

1 reference

8 September 2017

1537-1545

1 reference

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world

8 September 2017

1 reference

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

21 January 2018

1 reference

Clinicopathological and prognostic significance of HER-2/neu and VEGF expression in colon carcinomas

21 January 2018

1 reference

Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer

21 January 2018

1 reference

HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target

21 January 2018

1 reference

Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab.

21 January 2018

1 reference

Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: a European and USA International collaborative analysis.

21 January 2018

1 reference

Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome.

21 January 2018

1 reference

Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancer

21 January 2018

1 reference

Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin).

21 January 2018

1 reference

PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients.

21 January 2018

1 reference

Ubiquitin ligases: cell-cycle control and cancer

21 January 2018

1 reference

SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction

21 January 2018

1 reference

Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7.

21 January 2018

1 reference

p53-Altered FBXW7 expression determines poor prognosis in gastric cancer cases.

21 January 2018

1 reference

miR-23a promotes the transition from indolent to invasive colorectal cancer

21 January 2018

1 reference

Upregulation of miR-27a contributes to the malignant transformation of human bronchial epithelial cells induced by SV40 small T antigen

21 January 2018

1 reference

The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia

21 January 2018

1 reference

microRNAs in cancer management.

21 January 2018

1 reference

miRNAs, cancer, and stem cell division

21 January 2018

1 reference

Oncomirs - microRNAs with a role in cancer

21 January 2018

1 reference

Overexpression of microRNA-223 regulates the ubiquitin ligase FBXW7 in oesophageal squamous cell carcinoma

21 January 2018

1 reference

Catecholamine-Induced β2-adrenergic receptor activation mediates desensitization of gastric cancer cells to trastuzumab by upregulating MUC4 expression

21 January 2018

1 reference

MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab

21 January 2018

1 reference

MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma.

21 January 2018

1 reference

Up-regulation of miR-21 mediates resistance to trastuzumab therapy for breast cancer

21 January 2018

1 reference

The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine

21 January 2018

1 reference

Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene

21 January 2018

1 reference

Inactivation of hCDC4 can cause chromosomal instability

21 January 2018

1 reference

FBXW7/hCDC4 is a general tumor suppressor in human cancer.

21 January 2018

1 reference

Survival prediction of gastric cancer by a seven-microRNA signature

21 January 2018

1 reference

MicroRNA-223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4.

21 January 2018

1 reference

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

21 January 2018

1 reference

MicroRNA 223 is upregulated in the multistep progression of Barrett's esophagus and modulates sensitivity to chemotherapy by targeting PARP1

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.29168

1 reference

8 September 2017

1 reference